دورية أكاديمية

Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial

التفاصيل البيبلوغرافية
العنوان: Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial
المؤلفون: O'Donnell, Elizabeth *, Mo, Clifton, Yee, Andrew J, Nadeem, Omar, Laubach, Jacob, Rosenblatt, Jacalyn, Munshi, Nikhil, Midha, Shonali, Cirstea, Diana, Chrysafi, Pavlina, Horick, Nora, Richardson, Paul G, Raje, Noopur
المصدر: In The Lancet Haematology June 2024 11(6):e415-e424
قاعدة البيانات: ScienceDirect
الوصف
تدمد:23523026
DOI:10.1016/S2352-3026(24)00070-X